Appendix
Agendas for Information-Gathering Meetings

Meeting I

December 16–17, 2002

The National Academy of Sciences Building

2101 Constitution Avenue, NW

Washington, DC

 

Monday, December 16, 2002

1:15 p.m.

Introductory Remarks

Leslie Benet, Ph.D., Chair, Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents

 

Introductions by Committee Members and Meeting Attendees

1:30

Sponsor Presentation on the Study Charge

Carol Linden, Ph.D., Director, Medical Chemical and Biological Defense Research Program, U.S. Army Medical Research and Materiel Command

 

Congressional Comment on the Study Charge

Mr. Jean Reed, Professional Staff Member, House Armed Services Committee

 

Discussion

2:30

Status of Department of Defense Effort on Accelerating Research, Development, and Acquisition of Medical Countermeasures

Anna Johnson-Winegar, Ph.D., Deputy Assistant to the Secretary of Defense for Chemical and Biological Defense

 

Discussion

3:15

Break



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 5
Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents: Interim Report Appendix Agendas for Information-Gathering Meetings Meeting I December 16–17, 2002 The National Academy of Sciences Building 2101 Constitution Avenue, NW Washington, DC   Monday, December 16, 2002 1:15 p.m. Introductory Remarks Leslie Benet, Ph.D., Chair, Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents   Introductions by Committee Members and Meeting Attendees 1:30 Sponsor Presentation on the Study Charge Carol Linden, Ph.D., Director, Medical Chemical and Biological Defense Research Program, U.S. Army Medical Research and Materiel Command   Congressional Comment on the Study Charge Mr. Jean Reed, Professional Staff Member, House Armed Services Committee   Discussion 2:30 Status of Department of Defense Effort on Accelerating Research, Development, and Acquisition of Medical Countermeasures Anna Johnson-Winegar, Ph.D., Deputy Assistant to the Secretary of Defense for Chemical and Biological Defense   Discussion 3:15 Break

OCR for page 5
Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents: Interim Report 3:30 CBER Perspective on Opportunities for Accelerating Licensure of Medical Counter-measures for Biowarfare Agents Kathryn Zoon, Ph.D., Director, Center for Biologics Evaluation and Research, Food and Drug Administration   Discussion 4:15 CDER Perspective on Opportunities for Accelerating Licensure of Medical Countermeasures for Biowarfare Agents Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research, Food and Drug Administration   Discussion 5:00 Adjourn   Tuesday, December 17, 2002 8:00 a.m. Breakfast 8:30 Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military IOM Report, September 2002 Stanley Lemon, M.D., Chair, IOM Committee on a Strategy for Minimizing the Impact of Naturally Occurring Infectious Diseases of Military Importance: Vaccine Issues in the U.S. Military   Discussion 9:15 DoD Acquisition of Vaccine Production Report to the Deputy Secretary of Defense, December 2000 Gerald V.Quinnan, Jr., M.D., Professor and Chair of Preventive Medicine, Uniformed Services University of the Health Sciences   Discussion 10:00 Adjourn

OCR for page 5
Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents: Interim Report Meeting II January 14–15, 2003 The National Academies Building 500 Fifth Street, NW Washington, DC   Tuesday, January 14, 2003 9:00 a.m. Breakfast 9:30 Introductory Remarks Leslie Benet, Ph.D., Chair, Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents 9:45 Medical Countermeasures for Biological Warfare Agents Research Carried out at/through the U.S. Army Medical Research and Materiel Command (USAMRMC) Carol Linden, Ph.D., Director, Medical Chemical and Biological Defense Research Program, USAMRMC 10:30 Break 10:45 Chemical and Biological Medical Systems (CBMS) (formerly Joint Vaccine Acquisition Program) COL David Danley, Ph.D., Director, CBMS 11:30 DynPort Vaccine Company LLC Michael J.Langford, Ph.D., Senior Vice President and Chief Scientific Officer, DynPort Vaccine Company LLC 12:00 p.m. Working Lunch 12:45 Defense Threat Reduction Agency (DTRA) LTC Keith R.Vesely, D.V.M., Ph.D., Chief, Medical Science and Technology Division, Chemical and Biological Defense Directorate 1:15 Defense Advanced Research Projects Agency (DARPA) John Carney, Ph.D., Unconventional Pathogen Countermeasures Program 1:45 Joint Program Executive Office for the Chemical and Biological Defense Program (JPEO-CBDP) BG Steve Reeves, Program Executive Officer, Chemical and Biological Defense

OCR for page 5
Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents: Interim Report 2:15 Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear (JRO-CBRN) Defense MAJ Ronald Fizer, Joint Requirements Integrator, JRO-CBRN Defense 2:45 Break 3:00 Directed Roundtable Discussion: Representatives of Involved Government and Other Organizations   For each category, a set of questions was circulated to direct to the group   3:00 I Basic Research Early Development   3:45 II Transition to Advanced Development   4:30 III Advanced Development Licensure 5:30 Summary and General Discussion 6:00 Adjourn